All News

Meeting audience conference

World Congress on OP, OA & MSK Disorders

d EurekAlert!

Bone and musculoskeletal disease researchers and physicians from around the world will meet today in London, UK for the opening of the largest scientific event in the field, the World Congress on Osteoporosis, Osteoarthritis and Muscul

Read Article
brain headache neuro

Neuropsychiatric SLE - 2/3 Improved at 12 Months

d Jack Cush, MD

The management and outcomes of neuropsychiatric systemic lupus erythematosus (NPSLE) can be challenging as there is limited data. 

Read Article
FDG,PET,CT

Best Imaging in Giant Cell Arteritis - US, PET, MRI?

d Jack Cush, MD

Imaging is often instrumental in diagnosing and staging patients diagnosed with giant cell arteritis (GCA).

Read Article
Malar,rash,SLE, Lupus

JAMA: SLE Review

d Jack Cush, MD

Drs. Caroline Siegel and Lisa Sammaritano (from HSS in NYC) have published an impressive overview of systemic lupus erythematosus (SLE) in JAMA. This timely, well-written review covers the many complexities of this multi-organ disorder that affects nearly 3.4 million people worldwide.

Read Article
April Armstrong RNL

ICYMI: Co-management of Psoriatic Disease

d Richard Conway, MBBChBAO, PhD

It is a common clinical scenario to see someone with both severe psoriatic arthritis and skin psoriasis. In an ideal world this would involve a combined clinic with our local friendly dermatologist. For many of us, however, this is not practical for many reasons. The excellent Saturday morning session on choosing systemic therapies in psoriatic disease at RheumNow Live 2024 from dermatologist extraordinaire Dr. April Armstrong was therefore hugely insightful.

Read Article
Seasonal Pathogens and Henoch-Schönlein Purpura Epidemiologic studies of Henoch-Schönlein purpura (HSP) have suggested seasonal variation in occurrence rates (higher from September-April, lower in June-August), suggesting a role for infectious triggers. https://t.co/MmuVVziqv8 https://t.co/PhidOFTbFV

Links:

Dr. John Cush RheumNow ( View Tweet)
Pearl: Patients with persistent TMJ pain are more likely to have fibromyalgia than inflammatory or degenerative arthritis (as the underlying cause of their chronic pain) https://t.co/gCEm8A3RAT https://t.co/bvK2ii4fXP

Links:

Dr. John Cush RheumNow ( View Tweet)
IL-1 recept accessory protein (IL1RAP) shown to block mediators (IL-1, IL33, IL36) that may drive systemic sclerosis. In vitro, IL1RAP inhibited fibroblasts and endothelial cells; in mouse models of SSc anti-IL1RAP decr dermal & pulmonary fibrosis. https://t.co/jWjUMKdqGw https://t.co/O3o5iDHD6X

Links:

Dr. John Cush RheumNow ( View Tweet)
ICYMI: Top 5 Clinical Pearls in RA Management https://t.co/DphF8HcuHD https://t.co/CF9UuBCUxS

Links:

Dr. John Cush RheumNow ( View Tweet)
SLE in JAMA (authored by Drs Siegel & Sammaritano at HSS), impressive, full-read review, Covers: - Presentations: skin, Jts, brain, heme, etc - Treatments - Prognosis - Complications: CV, infx, CA - FAQs https://t.co/TPkm3BlrSw https://t.co/FqN1ZXyv4Y

Links:

Dr. John Cush RheumNow ( View Tweet)
1/600 Falls May Die (4.5.2024) Dr. Jack Cush reviews the news and Journal reports from this past week on RheumNow- including problems w/ falls, pain and treatment of Dupuytren’s contractures. https://t.co/37JSS1fbLi https://t.co/WEwjntAQEt

Links:

Dr. John Cush RheumNow ( View Tweet)
Serious Infections in Takayasu arteritis The large vessel vasculitis, Takayasu arteritis (TAK), carries a significant morbid risk and a cohort analysis shows these patients are also at high risk of serious infection with resultant higher risk of death. https://t.co/qqtpCMYnZf https://t.co/ZlxATKVQIA

Links:

Dr. John Cush RheumNow ( View Tweet)
Canadian OBRI study in 692 RA pts shows pts treated w/ triple DMARD (MSH) stayed on Rx longer (15 mos) compared to MTX+LEF (9.6 mos); not significant but MTX/SSZ/HCQ had signif lower DAS28 @ 6 mos (3.4 vs 3.9) & at 12 mos (3.2 vs 3.5, p=0.0005) https://t.co/tuIigaswDK https://t.co/DAh3lgRufA

Links:

Dr. John Cush RheumNow ( View Tweet)
Primary care pop. study pts shows poor health literacy in gout pts assoc. w/ more gout flares. Study of 551pts; 30% w/ 2+ flares in 12 mos; 9.4% w/ poor health literacy. pts had more flares (OR 4.1) & hx of oligo/polyarticular flares (OR 1.93) https://t.co/tDiFqixbLV https://t.co/Kb75iJwTZE

Links:

Dr. John Cush RheumNow ( View Tweet)
#RNL2024 @RheumNow @AlexisOgdie Many therapies for SpA - but ONLY TNFi, IL17i, and JAKi for AxSpA Check out https://t.co/3918uYvdFj to help guide treatment decisions: Prior therapies? enthesitis? concomitant IBD/uveitis? comorbidities? Pt preferences? https://t.co/6ugueBPMTy

Links:

Dr. John Cush RheumNow ( View Tweet)

TAPIR study shows that GPA patients treated with rituximab can be safely weaned off low dose prednisone. But. 20% risk of relapse in those treated with non-RTX regimens ⁦@VasculitisBCN24⁩ #vasculitis https://t.co/jDy0lOQQIP

Links:

Catherine Hill CatherineL_Hill ( View Tweet)
Human touch. A systematic review that underscores the physical and mental health benefits. The essence of medicine that will not be provided by #AI https://t.co/OvCDJYAsoS @NatureHumBehav @j_packheiser @helenahhartmann @FredericMichon @GazzolaValeria @sbl_nin https://t.co/YuAiKtq87p https://t.co/Sxj1LfO5ZG

Links:

Eric Topol EricTopol ( View Tweet)
Expert Review Rheumatoid Arthritis: The Continuum of Disease and Strategies for Prediction, Early Intervention, and Prevention 📰 https://t.co/JfkO8WpELc #rheumatoidarthritis #prediction #prevention https://t.co/3xqHalhjCV

Links:

The Journal of Rheumatology jrheum ( View Tweet)
2018 ACR/National Psoarasis Foundation Guidelines for Treatment of PsA - Created helpful definitions of Severe PsA and Severe PsO #RNL2024 @RheumNow @AlexisOgdie https://t.co/mYOWNEevfW

Links:

Dr. John Cush RheumNow ( View Tweet)

#RNL2024 @RheumNow @_AprilArmstrong Choosing a biologic in Psoriasis TNF - great in PsA, pregnancy. Avoid in demyelinating, hep B IL-17 - robust skin, PsA (axial too). Avoid in IBD IL-23 - robust skin, PsA evidence, fewer injections https://t.co/42kUaIZxKs

Links:

Dr. John Cush RheumNow ( View Tweet)

×